Ignite Creation Date:
2024-05-06 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05041166
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2023-09-28
First Post:
2021-09-02
Brief Title:
A Study of 13CPyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Optimized In-Human 13CPyruvate MRI For Assessment Of Physiologic Reference Data In Different Organs
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to learn about the use of 13Cpyruvate as an imaging agent for MRI scans In past studies researchers have seen that 13Cpyruvate can improve imaging with MRI scans However they would like to know more about how the imaging agent is distributed in healthy organs and tissues This study will provide additional information about the use of 13Cpyruvate as an imaging agent for MRI scans and it will show us how the substance is metabolized changed into energy in the organs and tissues of healthy volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None